News

Aceragen, Inc. to Delist from The Nasdaq Stock Market

  • DURHAM, N.C. and EXTON, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Aceragen, Inc. (the “Company”) (Nasdaq: ACGN), announced today that the Company intends to voluntarily terminate the listing of its common stock on the Nasdaq Capital Market (“Nasdaq”) by filing a Form 25 with the Securities and Exchange Commission (the “SEC”) on or about August 15, 2023. As previously disclosed, on August 14, 2023, the Company expects to hold a special meeting seeking stockholder approval to effect a transfer and assignment of substantially all of the Company's assets to an assignee for the benefit of creditors (the “Assignment Proposal”). Subject to stockholder approval of the Assignment Proposal, and in order to ensure an orderly delisting process, the Company has determined to voluntarily terminate the listing of its common stock on the Nasdaq by filing a Form 25 with the SEC on or about August 15, 2023.
    08/04/2023
Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

The price of Aceragen, Inc. (ACGN) is 0.3849 and it was updated on 2024-07-02 06:55:05.

Currently Aceragen, Inc. (ACGN) is in undervalued.

SEC Filings
SEC Filings

Aceragen, Inc. (ACGN) - 15-12G

  • SEC Filings
  • 08/28/2023

Aceragen, Inc. (ACGN) - EFFECT

  • SEC Filings
  • 08/18/2023

Aceragen, Inc. (ACGN) - S-8 POS

  • SEC Filings
  • 08/16/2023

Aceragen, Inc. (ACGN) - POS AM

  • SEC Filings
  • 08/16/2023

Aceragen, Inc. (ACGN) - 25

  • SEC Filings
  • 08/16/2023

Aceragen, Inc. (ACGN) - PRE 14A

  • SEC Filings
  • 07/11/2023

Aceragen, Inc. (ACGN) - DEFA14A

  • SEC Filings
  • 07/11/2023

Aceragen, Inc. (ACGN) - SC 13D

  • SEC Filings
  • 03/28/2023

Aceragen, Inc. (ACGN) - SC 13G/A

  • SEC Filings
  • 02/14/2023

Aceragen, Inc. (ACGN) - S-8

  • SEC Filings
  • 02/01/2023

Aceragen, Inc. (ACGN) - SC 13D/A

  • SEC Filings
  • 01/30/2023
Unlock
ACGN Ratings Summary
ACGN Quant Ranking